David A. Siegel Bio Techne Corp Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Bio Techne Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 42,000 shares of TECH stock, worth $3.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

42,000

Previous 56,300 25.4%

Holding current value

$3.01 Million

Previous $4.34 Million 31.95%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$65.98 - $77.09 $943,514 - $1.1 Million	-14,300 Reduced 25.4%	42,000 $2.96 Million
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $6.27 Million - $9.28 Million	-118,668 Reduced 67.82%	56,300 $4.34 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $1.41 Million - $1.87 Million	-20,900 Reduced 10.67%	174,968 $11.9 Million
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $13.9 Million - $16.2 Million	-188,600 Reduced 49.05%	195,868 $16 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $11.3 Million - $13.6 Million	157,500 Added 69.39%	384,468 $28.5 Million

Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $12.5 Million - $54.8 Million	155,476 Added 217.47%	226,968 $18.8 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $13.9 Million - $19.3 Million	49,300 Added 222.15%	71,492 $20.3 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $13.9 Million - $19.3 Million	49,300 Added 222.15%	71,492 $20.3 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $2.16 Million - $3.01 Million	6,692 Added 43.17%	22,192 $7.69 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $1.09 Million - $1.51 Million	-3,092 Reduced 16.63%	15,500 $6.71 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $5.74 Million - $6.61 Million	12,592 Added 209.87%	18,592 $9.62 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $2.67 Million - $3.23 Million	6,000 New	6,000 $2.91 Million
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $1.68 Million - $2.19 Million	-6,792 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $1.58 Million - $1.92 Million	6,792 New	6,792 $1.68 Million
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $439,075 - $518,394	-2,392 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $451,418 - $515,308	2,392 New	2,392 $499,000
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $403,395 - $558,444	-2,736 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $434,700 - $496,740	-3,000 Reduced 52.3%	2,736 $405,000
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $754,054 - $866,365	5,736 New	5,736 $866,000
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $705,815 - $784,918	-5,825 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $661,661 - $721,018	5,825	5,825 $704,000

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.81B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account